loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Cycloserine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Cycloserine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 650Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NRx Pharmaceuticals Presents Landmark NRX-101 Trial For Suicidal Bipolar
    NRx Pharmaceuticals Presents Landmark NRX-101 Trial For Suicidal Bipolar

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-presents-landmark-trial-of-nrx-101-in-suicidal-bipolar-depression-at-the-american-society-of-clinical-psychopharmacology-annual-meeting-nrx-101-is-the-first-oral-antidepressant-demonstrated-to-re-302156419.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    NRx keeps antidepressant's blockbuster hopes alive despite flop
    NRx keeps antidepressant's blockbuster hopes alive despite flop

    30 Apr 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/despite-trial-miss-nrx-pushes-antidepressant-forward-phase-3-patients-bipolar-depression

    FIERCE BIOTECH
    30 Apr 2024
    Share Share
    Drugs for TB, hypertension and antacids amongst those failing quality tests
    Drugs for TB, hypertension and antacids amongst those failing quality tests

    26 Dec 2019

    // LIVE MINT

    https://www.livemint.com/companies/news/drugs-for-tb-hypertension-and-antacids-amongst-those-failing-quality-tests-11577182667784.html

    LIVE MINT
    26 Dec 2019
    Share Share
    NeuroRx Receives FDA Breakthrough Therapy Designation for NRX-101
    NeuroRx Receives FDA Breakthrough Therapy Designation for NRX-101

    13 Nov 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20181113005407/en/NeuroRx-Receives-FDA-Breakthrough-Therapy-Designation-NRX-101/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    13 Nov 2018
    Share Share
    Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
    Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection

    19 Sep 2016

    // EDQM

    https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf

    EDQM
    19 Sep 2016
    Share Share
    Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility
    Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility

    05 Feb 2016

    // TWOFOUR INSIGHT

    http://twofourinsight.com/strides-shasun-receives-positive-who-inspection-report-formulation-facility/

    TWOFOUR INSIGHT
    05 Feb 2016
    Share Share